Holen Sie sich die Stockscreener-App
15.48
0.78%
0.12
Handel nachbörslich:
15.65
0.17
+1.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$15.36
Offen:
$15.33
24-Stunden-Volumen:
2.82M
Relative Volume:
0.94
Marktkapitalisierung:
$3.27B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-7.4783
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
-2.82%
1M Leistung:
+0.06%
6M Leistung:
-18.31%
1J Leistung:
-39.17%
1-Tages-Spanne:
$15.12
$15.59
1-Wochen-Bereich:
$15.12
$15.86
52-Wochen-Spanne:
$12.16
$27.95
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
15.48 | 3.27B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
515.09 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
169.72 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.35 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
254.52 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
216.70 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Deadline to Submit Claims for the $84M Dentsply Sirona Settlement is October 7, 2025 - TradingView
Dental Implants and Prosthetics Market worth US$18.79 billion - openPR.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Dental Prosthetics Market Report 2025: Global Analysis, Size, Share, Trends, and Forecast to 2032 - GlobeNewswire Inc.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 27, 2025 in Dentsply Lawsuit – XRAY - ACCESS Newswire
Should Value Investors Buy Dentsply Sirona (XRAY) Stock? - Yahoo Finance
Air Driven Dental Handpiece Market: Investment Analysis & - openPR.com
3D Multilayer Zirconia Blocks Market Deep Research Report with - openPR.com
Endodontic Irrigation Devices Market Generated - openPR.com
Dental Tungsten Carbide Bits Market: Executive Briefing & - openPR.com
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Periodontal Polishing Machine Market Forecast: Growth Trends, - openPR.com
DENTSPLY SIRONA (NASDAQ:XRAY) Has Announced A Dividend Of $0.16 - Yahoo Finance
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
DENTSPLY SIRONA Issues $550M Junior Subordinated Notes - TipRanks
Removable Partial Denture Market Future Business - openPR.com
Is the Options Market Predicting a Spike in Dentsply Sirona Stock? - The Globe and Mail
Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now - Nasdaq
Dental Soft-tissue Regeneration Market worth $0.53 billion in 2030 with 6.8% CAGR | MarketsandMarkets™ - PR Newswire UK
Dental Implants Market Is Booming So Rapidly 2025-2032 -DENTSPLY Sirona, Straumann AG, Bicon Dental Implants - openPR.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 27, 2025 in Dentsply Sirona Inc. LawsuitXRAY - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect - ACCESS Newswire
Dental Veneers Market Is Booming So Rapidly 2025-2032Dentsply - openPR.com
Intraoral Cameras Market Deep Research Report Shows Growth - openPR.com
Competitive Analysis of the Orthodontic Supplies Sector: Key Players include 3M, Align Technology, American Orthodontics, DB Orthodontics, Dentsply Sirona, G&H Orthodontics, Ormco, Argen & moreResearchAndMarkets.com - New Castle News
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of “Hold” from Analysts - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Squarepoint Ops LLC Sells 126,390 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) - Defense World
Dental Obturators Market Booming Worldwide with Advancements - openPR.com
North America Dental Equipment Market Detailed in New Research - openPR.com
Dentsply Sirona Announces $550 Million Notes Offering - TipRanks
Dentsply Sirona Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – XRAY - ACCESS Newswire
Lost Money on Dentsply Sirona Inc.(XRAY)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Dentsply Sirona sets $550 million notes offering By Investing.com - Investing.com South Africa
Dentsply Sirona (XRAY) Announces $550 Million Note Offering - GuruFocus
Dentsply Sirona sets $550 million notes offering - Investing.com
Dentsply Sirona Prices $550 Million Junior Subordinated Notes - MarketScreener
Dentsply Sirona Prices Offering of $550 million of Junior Subord - GuruFocus
Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes | XRAY Stock News - GuruFocus
Dentsply Sirona Inc Files Pricing Term Sheet For $550 Million 8.375% Junior Subordinated Notes Due 2055 - marketscreener.com
Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes - The Manila Times
Dentsply Sirona Secures Massive $550M Financing Deal with 8.375% Interest Rate Until 2030 - Stock Titan
Dentsply Sirona targets 2030 to make all packaging, including plastic, recyclable - Oral Health Group
Dental CAD CAM Market Analysis: Data-Driven Insights - openPR.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
XRAY Q1 Earnings Call: Margin Gains Amid Tariff and Market Pressures - Yahoo Finance
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages DENTSPLY SIRONA Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XRAY - ACCESS Newswire
Buying Dentsply Sirona (NASDAQ:XRAY) - Seeking Alpha
Advanced Dental Digital and Robotic Solutions Market Size 2025 - openPR.com
dentsply sirona amends credit and note agreements By Investing.com - Investing.com South Africa
Artisan Mid Cap Value Fund Sold Dentsply Sirona (XRAY) due to Weak Dental Market - Insider Monkey
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.43%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):